Xiaoli Wang, PhD
img_Xiaoli Wang
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Research Topics
Cancer, Cell Biology, Cell Transformation, Hematopoiesis, Stem Cells, Translational Research
Translational Research:
Development of therapeutic approaches for MPNs and MPN-BP (Post-MPN AML), Pre-clinical evaluation of therapeutic strategies for MPNs and MPN-BP (Post-MPN AML)
Clinical Research
Correlative biomarker studies in Phase I/II clinical trials
Laboratory Research
Normal and malignant hematopoiesis, Normal and malignant hematopoietic stem cell biology, Mechanisms underlying pathogenesis of chronic myeloproliferative neoplasms (MPN) and leukemic transformation (MPN-BP)

MD, Jilin Medical College

MS, Norman Bethune University of Medical Sciences

PhD, Jilin University

Icahn School of Medicine at Mount Sinai

Kansai Medical University

MF Challenge Concept Grant

The MPN Research Foundation (MPNRF) and the Leukemia & Lymphoma Society (LLS)

ASH Travel Award 2008

American Society of Hematology

ASH Travel Award 2009

American Society of Hematology

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Wang has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.